Twist Bioscience (TWST) Revenue (2017 - 2026)

Twist Bioscience has disclosed Revenue across 10 years of filings, most recently posting $110.7 million for Q1 2026.

• In Q1 2026, Revenue rose 19.31% year-over-year to $110.7 million; the TTM figure through Mar 2026 stood at $409.5 million (up 17.77% YoY), while the FY2025 annual figure was $376.6 million, up 20.32% from the prior year.
• Revenue rose to $110.7 million in Q1 2026, from $103.7 million in the prior quarter.
• Over the last five years, Revenue for TWST reached as high as $110.7 million in Q1 2026 and fell as low as $48.1 million in Q1 2022.
• The 5-year median for Revenue is $75.3 million (2024), against an average of $77.1 million.
• Annual changes were most pronounced in 2022 — Revenue soared 60.24% — and 2023, when it advanced 13.59%.
• A 5-year view of Revenue shows it stood at $54.2 million in 2022, then surged by 31.81% to $71.5 million in 2023, then climbed by 24.08% to $88.7 million in 2024, then increased by 16.89% to $103.7 million in 2025, then gained by 6.77% to $110.7 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $110.7 million, $103.7 million, and $99.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.